Apoptosis Induced by 13-S-hydroxyoctadecadienoic acid in the Breast Cancer Cell Lines, MCF-7 and MDA-MB-231

Document Type: Original Article

Authors

Department of Clinical Biochemistry, Cancer Research Laboratory, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Keywords


1. Lambrechts S, Decloedt J, Neven P. Breast cancer prevention: Lifestyle

changes and chemoprevention. Acta Clin Belg 2011; 66:283-

292.

2. Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment?

Mol Cancer Ther 2003; 2:573-580.

3. Brash AR. Lipoxygenases: Occurrence, functions, catalysis, and acquisition

of substrate. J Biol Chem 1999; 274:23679-23682.

4. Brash AR, Jisaka M, Boeglin WE, Chang MS, Keeney DS, Nanney LB,

 

et

al.

 

 

 

Investigation of a second 15s-lipoxygenase in humans and its

expression in epithelial tissues. Adv Exp Med Biol 1999; 469:83-

 

89.

 

5. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler

 

SA,

 

 

et al

. Decreased 13-s-hydroxyoctadecadienoic acid levels and

15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis

 

1999; 20:1985-1995.

 

6. Yuan H, Li MY, Ma LT, Hsin MK, Mok TS, Underwood MJ, Chen GG.

 

15-lipoxygenases and its metabolites 15(s)-hete and 13(s)-hode

 

in the development of non-small cell lung cancer. Thorax 2010;

 

65:321-326.

 

7. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE. 15-lipoxygenase-1

 

has anti-tumorigenic effects in colorectal cancer. Prostaglandins

 

Leukot Essent Fatty Acids 2004; 70:7-15.

 

8. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V,

 

 

 

et al.

 

. Reduced 15s-lipoxygenase-2 expression in esophageal cancer

specimens and cells and upregulation

in vitro

by the cyclooxygenase-

2 inhibitor, ns398. Neoplasia 2003; 5:121-127.

 

9. Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, Bergmann F,

 

 

et al.

TE.

15-lipoxygenase-1 production is lost in pancreatic cancer and

 

overexpression of the gene inhibits tumor cell growth. Neoplasia

 

2007; 9:917-926.

 

10. Jiang WG, Watkins G, Douglas-Jones A, Mansel RE. Reduction of isoforms

 

of 15-lipoxygenase (15-lox)-1 and 15-lox-2 in human breast

 

cancer. Prostaglandins Leukot Essent Fatty Acids 2006; 74:235-

 

245.

 

11. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE,

 

 

et al

.

15-lox-1: A novel molecular target of nonsteroidal anti-inflammatory

 

drug-induced apoptosis in colorectal cancer cells. J Natl

 

Cancer Inst 2000; 92:1136-1142.

 

12. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM. The histone deacetylase

 

inhibitor suberoylanilide hydroxamic acid induces apoptosis

 

via induction of 15-lipoxygenase-1 in colorectal cancer cells.

 

Cancer Res 2004; 64:8778-8781.

 

13. Kumar KA, Arunasree KM, Roy KR, Reddy NP, Aparna A, Reddy GV,

 

Reddanna P. Effects of (15s)-hydroperoxyeicosatetraenoic acid

 

and (15s)-hydroxyeicosatetraenoic acid on the acute- lymphoblastic-

 

leukaemia cell line jurkat: Activation of the fas-mediated

 

death pathway. Biotechnol Appl Biochem 2009; 52:121-133.

 

14. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM,

 

 

 

et

al.

 

 

 

15-lipoxygenase-1 mediates nonsteroidal anti-inflammatory

drug-induced apoptosis independently of cyclooxygenase-2 in

 

colon cancer cells. Cancer Res 2000; 60:6846-6850.

 

15. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS,

 

 

et al

. The critical

role of 15-lipoxygenase-1 in colorectal epithelial cell terminal

 

differentiation and tumorigenesis. Cancer Res 2005; 65:11486-

 

11492.

 

16. Pasqualini ME, Heyd VL, Manzo P, Eynard AR. Association between

 

e-cadherin expression by human colon, bladder and breast cancer

 

cells and the 13-hode:15-hete ratio. A possible role of their

 

metastatic potential. Prostaglandins Leukot Essent Fatty Acids

 

2003; 68:9-16.

 

17. Cimen I, Tuncay S, Banerjee S. 15-lipoxygenase-1 expression suppresses

 

the invasive properties of colorectal carcinoma cell lines

 

hct-116 and ht-29. Cancer Sci 2009; 100:2283-2291.

 

18. Youssef J, Badr M. Peroxisome proliferator-activated receptors

 

and cancer: Challenges and opportunities. Br J Pharmacol

 

2011;164:68-82.

 

19. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors

 

and lipid physiology: Opening the x-files. Science 2001; 294:1866-

 

1870.

 

20. Foreman JE, Sharma AK, Amin S, Gonzalez FJ, Peters JM. Ligand

 

activation of peroxisome proliferator-activated receptor-beta/

 

delta (pparbeta/delta) inhibits cell growth in a mouse mammary

 

gland cancer cell line. Cancer Lett 2010; 288:219-225.

 

21. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM,

 

 

 

et

al

 

 

 

. Oxidative metabolism of linoleic acid modulates ppar-beta/

delta suppression of ppar-gamma activity. Oncogene 2006;

 

25:1225-1241.

 

22. Sigal E, Grunberger D, Highland E, Gross C, Dixon RA, Craik CS.

 

Expression of cloned human reticulocyte 15-lipoxygenase and

 

immunological evidence that 15-lipoxygenases of different cell

 

 

659

13(S)-HODE Tavakoli-Yaraki M et al

Iran J Basic Med Sci; Vol. 16, No. 4, Apr 2013

types are related. J Biol Chem 1990; 265:5113-5120.

23. Mahipal SV, Subhashini J, Reddy MC, Reddy MM, Anilkumar K, Roy

KR,

et al

. Effect of 15-lipoxygenase metabolites, 15-(s)-hpete and

15-(s)-hete on chronic myelogenous leukemia cell line k-562: Reactive

 

oxygen species (ros) mediate caspase-dependent apoptosis.

 

Biochem Pharmacol 2007; 74:202-214.

 

24. Kim JH, Chang JH, Yoon JH, Lee JG, Bae JH, Kim KS. 15-lipoxygenase-1

 

induced by interleukin-4 mediates apoptosis in oral cavity cancer

 

cells. Oral Oncol 2006; 42:825-830.

 

25. Viita H, Pacholska A, Ahmad F, Tietavainen J, Naarala J, Hyvarinen

 

A,

 

 

et al.

15-lipoxygenase-1 induces lipid peroxidation and apoptosis,

and improves survival in rat malignant glioma.

 

 

In Vivo

2012;

26:1-8.

 

26. Glinghammar B, Skogsberg J, Hamsten A, Ehrenborg E. Ppardelta

 

activation induces cox-2 gene expression and cell proliferation

 

in human hepatocellular carcinoma cells. Biochem Biophys Res

 

Commun 2003; 308:361-368.

 

27. Stephen RL, Gustafsson MC, Jarvis M, Tatoud R, Marshall BR, Knight

 

D,

 

 

et al

. Activation of peroxisome proliferator-activated receptor

delta stimulates the proliferation of human breast and prostate

 

cancer cell lines. Cancer Res 2004; 64:3162-3170.

 

28. Yin Y, Russell RG, Dettin LE, Bai R, Wei ZL, Kozikowski AP,

 

 

et al

. Peroxisome

proliferator-activated receptor delta and gamma agonists

 

differentially alter tumor differentiation and progression during

 

mammary carcinogenesis. Cancer Res 2005; 65:3950-3957.

 

29. Ghosh M, Ai Y, Narko K, Wang Z, Peters JM, Hla T. Ppardelta is protumorigenic

 

in a mouse model of cox-2-induced mammary cancer.

 

Prostaglandins Other Lipid Mediat 2009; 88:97-100.

 

30. Glasgow WC, Hui R, Everhart AL, Jayawickreme SP, Angerman-

 

Stewart J, Han BB,

 

 

et al.

The linoleic acid metabolite, (13s)-hydroperoxyoctadecadienoic

acid, augments the epidermal growth

 

factor receptor signaling pathway by attenuation of receptor

 

dephosphorylation. Differential response in syrian hamster embryo

 

tumor suppressor phenotypes. J Biol Chem 1997; 272:19269-

 

19276.

 

31. Sauer LA, Dauchy RT, Blask DE, Armstrong BJ, Scalici S. 13-hydroxyoctadecadienoic

 

acid is the mitogenic signal for linoleic

 

acid-dependent growth in rat hepatoma 7288ctc

 

 

in vivo

. Cancer

Res 1999; 59:4688-4692.

 

32. Kelavkar UP, Cohen C, Kamitani H, Eling TE, Badr KF. Concordant

 

induction of 15-lipoxygenase-1 and mutant p53 expression in human

 

prostate adenocarcinoma: Correlation with gleason staging.

 

Carcinogenesis 2000; 21:1777-1787.

 

33. Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF. Overexpression

 

of 15-lipoxygenase-1 in pc-3 human prostate cancer

 

cells increases tumorigenesis. Carcinogenesis 2001; 22:1765-1773.